Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era

Author： Gilliland F.D.   Hunt W.C.   Key C.R.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.48, Iss.1, 1996-07, pp. : 67-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era

By Oefelein M.G.   Ricchiuti V.S.   Conrad P.W.   Goldman H.   Bodner D.   Resnick M.I.   Seftel A.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 120-124

Elsevier

Access to resources Recommend Favorite

Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer

By Gleave M.E.   Coupland D.   Drachenberg D.   Cohen L.   Kwong S.   Goldenberg S.L.   Sullivan L.D.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 708-712

Elsevier

Access to resources Recommend Favorite

Predictive Value of Prostate-specific Antigen, Tumour Stage and Tumour Grade for the Outcome of Bone Scintigraphy in Patients with Newly Diagnosed Prostate Cancer

By Rydh Anders   Tomic Radisa   Tavelin Björn   Hietala Sven-Ola   Damber Jan-Erik  

Scandinavian Journal of Urology and Nephrology, Vol. 33, Iss. 2, 1999-08 ,pp. : 89-93

Informa Healthcare

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite

Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing

By Paquette E.L.   Sun L.   Paquette L.R.   Connelly R.   Mcleod D.G.   Moul J.W.  

Urology, Vol. 60, Iss. 5, 2002-11 ,pp. : 756-759

Elsevier

Access to resources Recommend Favorite